(Q34631769)

3 August 2017

1 reference

title

Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment (English)

1 reference

3 August 2017

1 reference

Mark A Lewis

1

1 reference

3 August 2017

Andrea Wahner Hendrickson

series ordinal

2

1 reference

3 August 2017

Timothy J Moynihan

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

19 August 2011

1 reference

3 August 2017

1 reference

3 August 2017

volume

61

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

287-314

1 reference

Hypercalcemia of malignancy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical practice. Hypercalcemia associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hypercalcemia in malignant and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical problem-solving. In search of....

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Common acute oncological emergencies: diagnosis, investigation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Insights on the pathology of kidney stone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Failure of Total Calcium Corrected for Protein, Albumin,and pH to Correctly Assess Free Calcium Status*

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Management of the adverse effects associated with intravenous bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Electrolyte complications of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Paraneoplastic syndromes: an approach to diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

Metabolic emergencies

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Letter: Renal function and electrolyte disturbances in normocalcaemic and hypercalcaemic patients treated with mithramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Mechanisms of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Response to "The Perspective of the International Osteoporosis Foundation on the Official Positions of the International Society for Clinical Densitometry," by John A. Kanis et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Treatment and prevention of bone complications from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Tumor-related hyponatremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Consequences of inadequate management of hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Diagnosis and management of hyponatremia in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Cisplatin-induced renal salt wasting syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Cyclophosphamide-associated complications: we need to be aware of SIADH and central pontine myelinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Syndrome of inappropriate secretion of antidiuretic hormone associated with imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The syndrome of inappropriate antidiuretic hormone: current and future management options

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical practice. The syndrome of inappropriate antidiuresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Diagnosis and management of hyponatraemia in hospitalised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Mechanisms, risks, and new treatment options for hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Case report: focal nesidioblastosis ("nesidioblastoma") in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The insulin-like growth factor system and sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

Solitary fibrous tumor

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

A case of hypoglycemia, lactic acidosis, and hematologic malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Neuroendocrine responses to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Preventing hypoglycaemia: what is the appropriate glucose alert value?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Tumour lysis syndrome in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Tumor lysis syndrome in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours. Report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Tumour lysis syndrome: new therapeutic strategies and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Nebulized albuterol for acute hyperkalemia in patients on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The management of tumor lysis syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Cardiac tamponade: hemodynamic observations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

Acute cardiac tamponade

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Evaluation and management of pericardial effusion in patients with neoplastic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Etiology and prognostic implications of a large pericardial effusion in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Claude Beck: cardiac compression triads

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Pericardial effusion impending tamponade: a look beyond Beck's triad

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

How do the clinical findings in patients with pericardial effusions influence the success of aspiration?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical characteristics of malignant pericardial effusion associated with recurrence and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Superior vena caval stenting for SVC obstruction: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Superior vena caval obstruction. Is it a medical emergency?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The difficulties of a randomized study in superior vena caval obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Oncologic emergencies: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Microbiological data for patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Spinal cord compression in patients with advanced metastatic cancer: "all I care about is walking and living my life".

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

Spinal cord compression

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Extradural spinal cord compression: analysis of factors determining functional prognosis--prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Vertebral compression fractures: distinction between benign and malignant causes with MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Multiple spinal epidural metastases; an unexpectedly frequent finding

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The pathogenesis and treatment of brain metastases: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Increased intracranial pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The effect of large doses of dexamethasone on the cerebrospinal fluid pressure in patients with supratentorial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Current therapeutic approaches in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Management of hematological disorders and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hydroxyurea in the Prevention of the Effects of Leukostasis in Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Malignant airway obstruction: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Obstructing tracheal lipoma: management of a rare tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Endoscopic relief of malignant airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Management of malignant esophagotracheal fistulas with airway stenting and double stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Endoscopic treatment of malignant airway obstructions in 2,008 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Endobronchial palliation using Nd:YAG laser is associated with improved survival when combined with multimodal adjuvant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Outcomes of tracheobronchial stents in patients with malignant airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Endobronchial radiation therapy with or without neodymium yttrium aluminum garnet laser resection for managing malignant airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Extravasation of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

Docetaxel extravasation

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Prevention and management of extravasation of cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

European Oncology Nursing Society extravasation guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Symposium on the definition and management of anaphylaxis: summary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Clinical features and severity grading of anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.20124

21 January 2018

Identifiers

DOI

10.3322/CAAC.20124

1 reference

3 August 2017

1 reference